Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jul 10, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Preparing FIM-BCS," is looking at a new program designed to help Black women who have high blood pressure and obesity. The goal is to see if a 12-week intervention called RN-CHeFRx, which includes grocery delivery, cooking classes, and nutrition education, can help these women eat healthier and better manage their blood pressure. This is important because high blood pressure and obesity can increase the risk of heart disease, which is a major health concern for Black women in the U.S.
To participate in this trial, women need to be at least 18 years old, self-identify as Black or of African descent, and have a blood pressure reading of 130/85 or higher, or have a body mass index (BMI) of 30 or more, which indicates obesity. Participants will learn how to cook nutritious meals and make better food choices over the 12 weeks. However, those who cannot cook at home, have certain health issues, or are currently being treated for cancer cannot take part. If you're interested in improving your health through better nutrition and cooking, this trial might be a great opportunity!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • self-identified as Black or of African descent
- • female
- • ≥ 18 years old
- • baseline blood pressure ≥130/85 or diagnosed with hypertension and BMI ≥ 30
- Exclusion Criteria:
- • inability to cook in their homes
- • cognitive deficits impeding the ability to participate or provide informed consent
- • current treatment for cancer
- • liver or renal disease
- • pregnancy
- • lack of English language proficiency
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported